KEGG   DRUG: Alogliptin benzoate and pioglitazone hydrochloride
Entry
D10159            Mixture   Drug                                   
Name
Alogliptin benzoate and pioglitazone hydrochloride;
Liovel (TN);
Oseni (TN);
Incresync (TN)
Product
OSENI (Takeda Pharmaceuticals America)
  Generic
ALOGLIPTIN AND PIOGLITAZONE (Padagis Israel Pharmaceuticals)
Component
Alogliptin benzoate [DR:D06553], Pioglitazone hydrochloride [DR:D00945]
Class
Antidiabetic agent
 DG02044  Hypoglycemic agent
Remark
Therapeutic category: 3969
ATC code: A10BD09
Product: D10159<JP/US>
Efficacy
Antidiabetic
  Disease
Type 2 diabetes mellitus [DS:H00409]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 A ALIMENTARY TRACT AND METABOLISM
  A10 DRUGS USED IN DIABETES
   A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
    A10BD Combinations of oral blood glucose lowering drugs
     A10BD09 Pioglitazone and alogliptin
      D10159  Alogliptin benzoate and pioglitazone hydrochloride <JP/US>
USP drug classification [BR:br08302]
 Blood Glucose Regulators
  Antidiabetic Combinations
   Alogliptin Benzoate/ Pioglitazone Hydrochloride
    D10159  Alogliptin benzoate and pioglitazone hydrochloride
Therapeutic category of drugs in Japan [BR:br08301]
 3  Agents affecting metabolism
  39  Other agents affecting metabolism
   396  Antidiabetic agents
    3969  Others
     D10159  Alogliptin benzoate and pioglitazone hydrochloride
Drug groups [BR:br08330]
 Antidiabetic agent
  DG02044  Hypoglycemic agent
   D10159  Alogliptin benzoate and pioglitazone hydrochloride
Drug classes [BR:br08332]
 Antidiabetic agent
  DG02044  Hypoglycemic agent
   D10159  Alogliptin benzoate and pioglitazone hydrochloride
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10159
Other DBs
PubChem: 135626877
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system